• About Us
    • About Synexa
    • The Team
    • SynErgy
    • Operations
  • Services & Capabilities
    • Services Overview
    • Flow Cytometry Services
    • PBMC Isolation and Processing
    • Bioanalysis Solutions
    • Biomarker Solutions
    • Technology Platforms
    • Clinical Research Expertise
    • Custom Solutions & Novel Modalities
  • ProtoTrials®
  • Resource Library
    • Brochures
    • Datasheets
    • Webinars
  • News & Insights
    • News
    • Blog Articles
    • Feature Articles
  • Contact
Menu
  • About Us
    • About Synexa
    • The Team
    • SynErgy
    • Operations
  • Services & Capabilities
    • Services Overview
    • Flow Cytometry Services
    • PBMC Isolation and Processing
    • Bioanalysis Solutions
    • Biomarker Solutions
    • Technology Platforms
    • Clinical Research Expertise
    • Custom Solutions & Novel Modalities
  • ProtoTrials®
  • Resource Library
    • Brochures
    • Datasheets
    • Webinars
  • News & Insights
    • News
    • Blog Articles
    • Feature Articles
  • Contact

Archives: News

Synexa Life Sciences expands operations in North America with new Rockville laboratory site

Synexa Life Sciences expands operations in North America with new Rockville laboratory site

New site supports unique and seamless workflows that narrow the gap between preclinical and clinical phases

Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities

Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities

Expansion of leading biomarker and bioanalysis company enhances bioanalytical solutions for targeted radiopharmaceuticals.

Synexa Life Sciences announces strategic growth plans and strengthening of its executive team

Synexa Life Sciences announces strategic growth plans and strengthening of its executive team

Delivering on growth strategies to become the global market leader in specialist biomarker and bioanalytical services.

Synexa Life Sciences Co-founder and CEO to become company’s Chairman

Synexa Life Sciences Co-founder and CEO to become company’s Chairman

Leading biomarker and bioanalysis company lays the foundation for future growth and expansion plan.

Synexa Announces Tripartite Collaboration

Synexa Announces Tripartite Collaboration

Together with Paraxel and Drawbridge Health, Synexa offers a streamlined solution to COVID-19 serology testing.

Sign up to Synexa Insights
About Us
About Synexa
Leadership
SynErgy
Operations
Bioanalytical Science
Introduction
Pharmacokinetics
Immunogenicity
Resource Library
Brochures
Datasheets
Webinars
News & Insights
News
Blog Articles
Feature Articles

© Synexa Life Sciences BV 2022 | Privacy | Terms of Use | Cookies

Linkedin-in
Menu
  • About Us
    • About Synexa
    • The Team
    • SynErgy
    • Operations
  • Services & Capabilities
    • Services Overview
    • Flow Cytometry Services
    • PBMC Isolation and Processing
    • Bioanalysis Solutions
    • Biomarker Solutions
    • Technology Platforms
    • Clinical Research Expertise
    • Custom Solutions & Novel Modalities
  • ProtoTrials®
  • Resource Library
    • Brochures
    • Datasheets
    • Webinars
  • News & Insights
    • News
    • Blog Articles
    • Feature Articles
  • Contact
  • Sign up to Synexa Insights

News Signup

"*" indicates required fields

Consent*
*
Yes, I would like to receive email communications from Synexa Life Sciences and allow for my information to be used for any follow-up requests to evaluate potential products or services relevant to my requirements.

I understand I can manage my preferences or opt-out of communications with Synexa Life Sciences at any time using the unsubscribe link provided in all of email communications and can learn more by reading the privacy policy here.
This field is for validation purposes and should be left unchanged.

Talk to our Biomarker Experts